MRSA clone ST398-SCCmec IV as a cause of infections in an equine clinic by Hermans, Katleen et al.
Vlaams Diergeneeskundig Tijdschrift, 2008, 77 Short communication   429
INTRODUCTION
Staphylococcus aureus is an important pathogen,
both for animals and for humans. Resistance of this
bacterium to methicillin and all other beta-lactam
antimicrobial agents has been a point of major concern
for several decades, especially in human hospital
settings, since the so-called methicillin-resistant
S. aureus (MRSA) strains tend to accumulate
resistance genes to most other antibiotics as well,
making it difficult to treat infections with these strains.
Certain epidemic clones of these MRSA strains are
dis se minating in and between hospitals, causing major
outbreaks (Enright, 2003). In contrast to these hospital-
acquired (HA) MRSA strains, community-acquired
(CA) MRSA strains belong to different epidemic
clones and are generally less resistant to antimicrobial
agents other than β-lactams (Eady and Cove, 2003). 
The presence of MRSA in animals had already
been described in the early 70’s (Devriese et al., 1972),
but more recently the importance of MRSA’s in
veterinary medicine has been increasing, especially as
a cause of infection in intensive farm animals and as an
occupational health hazard for people in contact with
these animals (Voss et al., 2005; Moodley et al., 2006;
Wulf et al., 2006). Western European pigs appear to
be highly colonized by a porcine-related clone, namely
ST 398 (Voss et al., 2005; Guardabassi et al., 2007). In
horses, MRSA has also been described as a problem.
Outbreaks in equine clinics have been described in the
USA (Seguin et al., 1999) and Canada (Weese et al.,
2005), and several MRSA infections have been
identified in Irish horses (O’Mahony et al., 2005;
Maeda et al., 2007).
In a Belgian horse clinic it has been noted since the
end of 2005 that MRSA was increasingly being
isolated from clinical infections, often post-surgery. In
view of the possibility of the presence of a nosocomial
pathogen in this clinic, it was the aim of our study to
examine a possible epidemiological relationship
between the different MRSA isolates. 
MATERIALS AND METHODS
Thirteen MRSA strains isolated from hospitalized
patients over the period November 2005 through
December 2006 were included in this study. These
strains were associated with skin and wound infections
(n = 8), foreign body infection (n = 1), peritonitis
(n = 1), arthritis (n = 1) and respiratory tract infections
(n = 2) (Table 1). A single isolate per horse was
included. The horses all belonged to different owners
and originated from France (n = 2) and from 6
different Belgian provinces (n = 11). They were of
various breeds, gender and age. Between admission to
the clinic and the isolation of MRSA, they were treated
with various antimicrobial agents such as penicillin,
gentamicin, neomycin, trimethoprim-sulfonamide
combinations, ceftiofur and enrofloxacin. In several
cases, failure of the therapy was the reason for
submission of a sample for bacteriological analysis.
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ABSTRACT
Thirteen multidrug-resistant MRSA strains from infections of hospitalized horses in an equine clinic were
analyzed. They all were indigestible by SmaI restriction, possessed SCCmec type IV and belonged to spa type
t011. One isolate was analyzed by MLST and allotted to ST398. The MRSA clonal lineage ST398-SCCmec IV
appears to have a high capability of causing clinical infections in an equine hospital environment. 
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phenotypic methods such as colony morphology on
5% sheep blood agar (Gibco, Paisley, Scotland), Dnase
and acetoin production and growth on modified Baird-
Parker medium (Devriese, 1981), as well as by PCR
for detection of the femA gene (Mehrotra et al., 2000)
and tDNA-intergenic spacer PCR (Baele et al., 2000).
Oxacillin resistance was phenotypically assessed by
disk susceptibility testing on Isosensitest agar (Oxoid,
Basingstoke, UK) at 30°C, and by MIC determination
according to CLSI (2007), and additionally geno -
typically by detection of the mecA gene using the PCR
method of Mehrotra et al. (2000). Production of beta-
lactamase was assessed using beta-lactamase
diagnostic tablets (Rosco, Taastrup, Denmark).
Susceptibility was deter mined using MIC tests
according to CLSI (2007) for lincomycin, erythro -
mycin, tylosin, neomycin, genta micin, tetracycline,
enrofloxacin, trimethoprim and sulfonamides. For
lincomycin, tylosin and neo mycin, the resistance
assessment was based on bimodal distribution by
comparing the MIC values of the thirteen horse strains
with the MICs of S. aureus strains from other origins.
Furthermore, multiplex PCR reactions were performed
as previously described for the following resistance
genes: ermA, ermC, tetK, tetM, aac6’-aph2”, ant4’
and aph3’ (Denis et al., 2000). 
Genotyping of the strains was performed by Pulsed
Field Gel Electrophoresis (PFGE) according to the
protocol of Deplano et al. (2000), by SCCmec typing
as described by Oliveira and de Lencastre (2002) and
Zhang et al. (2005), and by spa typing (Harmsen et al.,
2003). Multilocus sequence typing (MLST) (Enright
et al., 2000) was carried out for one representative
strain. PCRs for Panton Valentine Leucocidin (PVL),
Toxic Shock Syndrome Toxin-1 (TSST-1) and
exfoliative toxins A and B were also performed on all
strains, as described previously (Lina et al., 1999;
Jarraud et al., 2002).
RESULTS
The results are shown in Table 2. In summary, the
strains were resistant to all beta-lactams. Ten strains
additionally showed resistance to macrolides and
lincosamides (ML) (ery thromycin, tylosin and
lincomycin) (through the ermC gene), to tetracycline
(encoded by tetM), and to gentamicin. Resistance to
neomycin was variable. The presence of amino -
glycoside resistance genes varied between strains.
There were three different MRSA strains, as they were
susceptible to ML. It was furthermore typical that all
strains showed resistance to trimethoprim and were
sensitive to sulfonamides. All isolates produced beta-
lactamase. 
Genotyping was first attempted by PFGE, but the
strains could not be digested with the SmaI restriction
enzyme. SCCmec and spa typing revealed that all
thirteen strains possessed SCCmec type IV and
belonged to spa type t011. By MLST, one
representative strain belonged to sequence type (ST)
398. The PCRs for PVL, TSST-1 and the exfoliative
toxins, A and B, were negative.
DISCUSSION
All the isolates included in this study were non-
typeable through PFGE using SmaI digestion,
contained SCCmec element IV  and belonged to spa
type t011. This characterizes them as belonging to the
ST398 clonal lineage (de Neeling, 2007; Witte et al.,
2007), which was confirmed in this study by MLST
typing of one representative isolate. S. aureus strains
belonging to the clonal lineage ST398 have long been
considered rare (Witte et al., 2007). They have been
most extensively described as isolates from infections
and from nasal colonization in pigs and in pig farmers
(Armand-Lefevre et al., 2005; de Neeling et al., 2007;
Guardabassi et al., 2007). This clone is typically
indigestible by the SmaI restriction enzyme due to the
presence of a novel DNA methylation enzyme (Bens et
al., 2006). Voss et al. (2005) suggested that this MRSA
strain was associated with pig farming and was able to
spread not only from pigs to humans, but also between
humans. 
On the other hand, MRSA strains belonging to
ST398 have been occasionally isolated in dogs and
Table 1. Isolation sites of MRSA strains from horses in this study.
Strain n° Lesion/sample from which the strain originated
10272 Peritoneal fluid from foal affected by peritonitis after explorative laparatomy
10773 Infection of incision site after abdominal surgery
06R314 Infection of incision site after abdominal surgery
06R1178 Infection of incision site after abdominal surgery
06R1335 Pacemaker infection
06R1415 Wound infection
06R1584 Tracheal sputum
06R1656 Tarsal joint infection 
06R1700 Funiculitis after castration
06R1971 Wound infection after conservative wound treatment
06R1990 Abdominal wound
06R1995 Swab from guttural pouch
06R2062 Abscess within mastocytoma
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horses (Witte et al., 2007): the equine strains were
isolated from sinusitis in a German foal and wound
infections in two Austrian horses. Surprisingly, all
thirteen strains that had been included in the present
study and had been isolated from patient infections in
the equine clinic over a period of more than one year,
belonged to the clonal lineage ST398-SCCmec IV.
Outbreaks in equine clinics have been described in the
USA (Seguin et al., 1999) and Canada (Weese et al.,
2005). However, in most veterinary hospital studies,
the MRSA strains isolated from animals belonged to
epidemic clones widely disseminated in human
hospitals (Loeffler et al., 2005; Weese et al., 2005). 
Since Voss et al. (2005) suggested that the “pig
associated” clone ST398 can be transmitted from
animals to humans and also between humans, it would
be advisable to screen the persons in contact with
hospitalized horses to examine them for carriership of
this strain. In the event of a positive result, these
people and their general practitioner would then be
aware of the situation and could take measures, if
necessary.  
Furthermore, the fact that this strain has been
isolated over a long time period in the equine clinic
merits further investigation. S. aureus carriership by
one or more of the clinic employees might have been
responsible for recurrent transmission to the horse
patients. High prevalence of MRSA strains has been
reported among veterinarians and veterinary students,
particularly those in contact with livestock
(Hanselman et al., 2006; Wulf et al., 2006). In the
study of Wulf et al. (2006), the MRSA strains isolated
from these persons were also not digestible by SmaI
and belonged to the related spa types t011, t034 and
t108.
However, it is also not unlikely that the clone can
persist in the clinical environment or on materials used
in the clinic, since it has been described that S. aureus
can persist in the dry environment from seven days up
to seven months (Kramer et al., 2006). In human
MRSA isolates, a better environmental survival rate
has been reported for outbreak as opposed to sporadic
strains (Wagenvoort et al., 2000).
As a third possibly important factor, the coloni -
zation rate of horses belonging to the healthy horse
population with this clonal MRSA lineage also
remains to be elucidated. It should be noted that the
antimicrobial resistance patterns of the thirteen isolates
included in this study were not completely identical,
which points to the fact that several subtypes of this
clone were implicated in the horses’ infections. This
may indicate that the horses might already have been
carriers of the MRSA strain upon admission to the
clinic. Research into this possibility is currently being
carried out.
In conclusion, it can be stated that the MRSA clonal
lineage ST398-SCCmec IV is capable of causing
infections in an equine hospital environment, and that
further research into the origin of this clone is needed. 
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Uit het verleden
VAN VUURPUNT TOT ACUPUNCTUUR
Op de figuren: een 19de eeuwse voorstelling van de mogelijke vuurlijnen of vuurpunten bij het paard en
een puntcauterisatieinset uit dezelfde tijd (Schenking Van den Abbeele - Veterinaire Museumcollectie Me-
relbeke). De set werkt als volgt. Een doorboorde metalen kogel wordt in het vuur verhit en met een aan-
gepaste tang in de cauterisator geplaatst. Men steekt een naald doorheen de kogel die zodoende lange tijd
verhit blijft. De diepte van de aan te brengen punten kan met schroefjes geregeld worden door de naald
meer of minder ver doorheen de kogel te laten uitsteken en vervolgens op de gewenste diepte te fixeren.
Kunstmatig ontsteking opwekken was samen met ‘aderlaten’ de meest wijd verspreide
diergeneeskundige ingreep vanaf de oudheid tot in de 19de eeuw. Men probeerde daarmee vooral
chronische processen te ‘activeren’ of ‘het kwaad’ uit te laten. Zowel inwendige als uitwendige
aandoeningen werden behandeld. Ook het profylactische gebruik was wijd verbreid bij dreigende
epidemieën. Drie types ingrepen werden toegepast:
1. Oppervlakkige hittecauterisatie: vuurpunten en vuurlijnen zetten op de huid. Dit werd vooral bij
paarden toegepast.
2. Kunstmatige ettervorming opwekken via het veroorzaken van zogenaamde fixatiefistels en
fixatieabcessen (vooral bij runderen). Een irriterende stof werd onderhuids ingespoten of op een
drager (drain, seton, metalen schijfjes) subcutaan ingebracht. De drager kon op zichzelf al een
aanslepende ‘vreemd voorwerp ontsteking’ opwekken.
3. Acupunctuur werd oorspronkelijk in het confuciaanse China niet zozeer voor pijnbestrijding of
anesthesie gebruikt. Dit was de meest milde vorm van ontsteking opwekken. De naalden werden
soms verhit. Deze met puntcauterisatie verwante methode werd ‘vuuracupunctuur’ genoemd.
Luc Devriese
